Novo Nordisk A/S
Copenhagen : NOVO B

May 31, 2011 04:36 ET

Total number of voting rights and share capital in Novo Nordisk A/S as of 31 May 2011

BAGSVAERD, DENMARK--(Marketwire - May 31, 2011) -


In accordance with Section 6 of the Danish Statutory Order on Issuers Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of the month where changes have occurred.

Referring to Company Announcement no 26/2011 dated 2 May 2011, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 31 May 2011.


Company Announcement no 34 2011: http://hugin.info/2013/R/1520109/456501.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1520109]

Contact Information

  • Media:

    Outside North America:
    Anne Margrethe Hauge
    Tel: (+45) 4442 3450
    Email Contact

    In North America:
    Ken Inchausti
    Tel: (+1) 609 514 8316
    Email Contact

    Investors:

    Klaus Bülow Davidsen
    Tel: (+45) 4442 3176
    Email Contact

    Jannick Lindegaard
    Tel: (+45) 4442 4765
    Email Contact

    Frank Daniel Mersebach
    Tel: (+45) 4442 0604
    Email Contact